UPDATE 1-Biotech company Novacyt seeks emergency approval for coronavirus testReuters | Washington DC | Updated: 07-02-2020 14:25 IST | Created: 07-02-2020 14:16 IST
Biotechnology company Novacyt has applied for an emergency approval from the U.S. Food & Drug Administration (FDA) as it races to roll out a product that tests for the coronavirus, the company said on Friday.
"As one of the first companies to develop and launch a test to detect the 2019 strain of nCoV (coronavirus), we have received unprecedented interest," Novacyt CEO Graham Mullis said. "We continue to support our new and existing customers and are working with the various regulatory authorities to try to make our nCoV test available to as many countries and laboratories as possible," he added.
(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)
Download The Devdiscourse News App for Latest News.